Organization Profile

Related Organization(s)

You just read:

Neovii & Mundipharma Confirm In-licensing Agreement for the Development and Promotion of Grafalon(R) in China and Japan for Solid Organ & Stem Cell Transplant

News provided by

Mundipharma

Jul 05, 2018, 06:32 ET